HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
K Aozasa Selected Research
K Aozasa Research Topics
Disease
10
Neoplasms (Cancer)
03/2012 - 02/2000
7
Lymphoma (Lymphomas)
12/2001 - 07/2000
5
Carcinoma (Carcinomatosis)
12/2001 - 02/2000
3
Prostatic Intraepithelial Neoplasia
03/2001 - 02/2000
3
T-Cell Lymphoma (Lymphoma, T Cell)
02/2001 - 04/2000
2
Neoplasm Metastasis (Metastasis)
09/2004 - 05/2001
2
Prostatic Neoplasms (Prostate Cancer)
11/2001 - 03/2001
2
Latent Infection
11/2000 - 07/2000
1
Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
05/2006
1
Sertoli Cell-Only Syndrome
08/2005
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2004
1
IGA Glomerulonephritis (IGA Nephropathy)
06/2004
1
Cysts
12/2001
1
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2001
1
Autoimmune Diseases (Autoimmune Disease)
10/2001
1
T-Cell Leukemia (Leukemia, T Cell)
03/2001
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2001
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2001
1
Sarcoma (Soft Tissue Sarcoma)
03/2001
1
Pleural Empyema (Pyothorax)
11/2000
1
Lymphangioleiomyomatosis (Lymphangiomyomatosis)
11/2000
1
Brain Neoplasms (Brain Tumor)
11/2000
1
Pleural Effusion (Pleural Effusions)
11/2000
1
Lethal Midline Granuloma
07/2000
1
Chromosome Aberrations (Chromosome Abnormalities)
05/2000
1
Inflammation (Inflammations)
05/2000
1
Leukemia
05/2000
1
Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
04/2000
1
Ovarian Neoplasms (Ovarian Cancer)
04/2000
Drug/Important Bio-Agent (IBA)
3
DNA (Deoxyribonucleic Acid)
IBA
03/2001 - 05/2000
2
MicroRNAs (MicroRNA)
IBA
03/2012 - 08/2011
2
CSK Tyrosine-Protein Kinase
IBA
03/2012 - 08/2011
2
NF-kappa B (NF-kB)
IBA
09/2004 - 11/2001
2
Proteins (Proteins, Gene)
FDA Link
12/2001 - 04/2000
2
Death-Associated Protein Kinases
IBA
12/2001 - 11/2000
2
Paraffin
IBA
03/2001 - 04/2000
2
Membrane Proteins (Integral Membrane Proteins)
IBA
11/2000 - 07/2000
2
WT1 Proteins
IBA
05/2000 - 02/2000
2
Peptides (Polypeptides)
IBA
05/2000 - 02/2000
1
Focal Adhesion Protein-Tyrosine Kinases
IBA
03/2012
1
Glycogen Synthase Kinases
IBA
03/2012
1
Integrins
IBA
03/2012
1
integrin-linked kinase
IBA
03/2012
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
05/2006
1
Stem Cell Factor
IBA
08/2005
1
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
IBA
08/2005
1
Inhibins (Inhibin)
IBA
08/2005
1
Valosin Containing Protein
IBA
09/2004
1
Cyclin D1
IBA
12/2001
1
Glucocorticoid Receptors (Glucocorticoid Receptor)
IBA
11/2001
1
Androgens
IBA
11/2001
1
Hormones (Hormone)
IBA
11/2001
1
Dexamethasone (Maxidex)
FDA Link
Generic
11/2001
1
Glucocorticoids
IBA
11/2001
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
10/2001
1
Autoantibodies
IBA
10/2001
1
Nucleotides
IBA
02/2001
1
Pesticides
IBA
02/2001
1
Antigens
IBA
11/2000
1
Messenger RNA (mRNA)
IBA
11/2000
1
Epstein-Barr Virus Nuclear Antigens
IBA
11/2000
1
Epitopes
IBA
11/2000
1
Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)
IBA
11/2000
1
Chromatin
IBA
11/2000
1
Interleukin-7 (Interleukin 7)
IBA
10/2000
1
HLA-A*02:01 antigen
IBA
07/2000
1
Interleukin-6 (Interleukin 6)
IBA
05/2000
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
05/2000
1
Neoplasm Antigens (Tumor Antigens)
IBA
05/2000
1
Histocompatibility Antigens Class I
IBA
05/2000
1
Fas Ligand Protein (Fas Ligand)
IBA
04/2000
1
Cell Extracts
IBA
02/2000
1
Fluconazole (Zonal)
FDA Link
Generic
02/2000
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
05/2001 - 11/2000
2
Lasers (Laser)
03/2001 - 09/2000
1
Therapeutics
05/2006
1
Kidney Transplantation
06/2004
1
Transplantation
03/2001
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2001
1
Radiotherapy
03/2001
1
Aftercare (After-Treatment)
03/2001
1
Laparotomy
11/2000
1
Immunotherapy
02/2000
1
Prostatectomy (Retropubic Prostatectomy)
02/2000